GlassScriptPhysician profile
Bradley D Beasley
NPI 1821102823
$3,615.33
in general payments reported to CMS, 2019-2025
22 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,238 · 2021: $1,419 · 2023: $202 · 2024: $194 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $958.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,064.87 | 2021 | |
| Pylant Medical | $1,037.49 | 2019-2023 | |
| Orpyx Medical Technologies INC. | $250.00 | 2021 | |
| Stryker Corporation | $199.50 | 2024-2025 | Infinity Adaptis, Iconix |
| Depuy Synthes Sales INC. | $158.07 | 2021-2025 | Motoband, N/A |
| Smith+Nephew, INC. | $142.95 | 2019-2025 | Collagenase Santyl |
| Amgen INC. | $122.93 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $122.19 | 2023 | Krystexxa |
| Organogenesis INC. | $121.83 | 2025 | Cygnus Dual, Nushield |
| Paratek Pharmaceuticals, INC. | $76.23 | 2025 | Nuzyra |
| In2bones USA, LLC | $53.11 | 2019 | |
| Abiomed | $39.04 | 2025 | |
| Kci USA, INC. | $34.84 | 2019 | |
| Averitas Pharma INC. | $30.02 | 2024 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $27.90 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $26.61 | 2025 | Exogen Ultrasound Bone Healing System |
| Globus Medical, INC. | $22.56 | 2025 | Senza |
| 4web, INC. | $22.31 | 2019 | |
| Abbott Laboratories | $16.57 | 2019 | |
| Melinta Therapeutics, LLC | $16.46 | 2019 | |
| Mimedx Group, INC. | $15.91 | 2024 | |
| Treace Medical Concepts, INC. | $13.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Beasley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.